These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21480826)

  • 21. Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach.
    Giaginis C; Zira A; Theocharis S; Tsantili-Kakoulidou A
    J Appl Toxicol; 2009 Nov; 29(8):724-33. PubMed ID: 19728316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental drug transporters.
    Unadkat JD; Dahlin A; Vijay S
    Curr Drug Metab; 2004 Feb; 5(1):125-31. PubMed ID: 14965255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human placenta--an alternative for studying foetal exposure.
    Myren M; Mose T; Mathiesen L; Knudsen LE
    Toxicol In Vitro; 2007 Oct; 21(7):1332-40. PubMed ID: 17624715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.
    Prouillac C; Lecoeur S
    Drug Metab Dispos; 2010 Oct; 38(10):1623-35. PubMed ID: 20606001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam.
    Myllynen P; Vähäkangas K
    J Pharmacol Toxicol Methods; 2002; 48(3):131-8. PubMed ID: 14986861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research on nanoparticles in human perfused placenta: State of the art and perspectives.
    Aengenheister L; Favaro RR; Morales-Prieto DM; Furer LA; Gruber M; Wadsack C; Markert UR; Buerki-Thurnherr T
    Placenta; 2021 Jan; 104():199-207. PubMed ID: 33418345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Models for placental transfer studies of drugs.
    Bourget P; Roulot C; Fernandez H
    Clin Pharmacokinet; 1995 Feb; 28(2):161-80. PubMed ID: 7736690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of dually labelled PEGylated liposomes transplacental passage and placental penetration using a combination of two ex-vivo human models: the dually perfused placenta and the suspended villous explants.
    Valero L; Alhareth K; Gil S; Simasotchi C; Roques C; Scherman D; Mignet N; Fournier T; Andrieux K
    Int J Pharm; 2017 Nov; 532(2):729-737. PubMed ID: 28757257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing pregnancy centered medications: drugs which do not cross the human placenta.
    Gedeon C; Koren G
    Placenta; 2006 Aug; 27(8):861-8. PubMed ID: 16313957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplacental transfer and metabolism of diuron in human placenta.
    Mohammed AM; Karttunen V; Huuskonen P; Huovinen M; Auriola S; Vähäkangas K
    Toxicol Lett; 2018 Oct; 295():307-313. PubMed ID: 30010034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta.
    Mortimer RH; Landers KA; Balakrishnan B; Li H; Mitchell MD; Patel J; Richard K
    Placenta; 2012 Apr; 33(4):252-6. PubMed ID: 22264585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal exposure to environmental chemicals; insights from placental perfusion studies.
    Mathiesen L; Buerki-Thurnherr T; Pastuschek J; Aengenheister L; Knudsen LE
    Placenta; 2021 Mar; 106():58-66. PubMed ID: 33647821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.
    Pavek P; Smutny T
    Drug Metab Rev; 2014 Feb; 46(1):19-32. PubMed ID: 24020384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer.
    Dallmann A; Liu XI; Burckart GJ; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S70-S81. PubMed ID: 31502693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposed study on the transplacental transport of parabens in the human placental perfusion model.
    Mathiesen L; Zuri G; Andersen MH; Knudsen LE
    Altern Lab Anim; 2013 Dec; 41(6):473-82. PubMed ID: 24512231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental methods to study human transplacental exposure to genotoxic agents.
    Vähäkangas K; Myllynen P
    Mutat Res; 2006 Sep; 608(2):129-35. PubMed ID: 16857420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the placenta in drug transport and fetal drug exposure.
    Koren G; Ornoy A
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):373-385. PubMed ID: 29307240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus.
    Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon.
    Simone C; Derewlany LO; Oskamp M; Knie B; Koren G
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1404-10. PubMed ID: 8178881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of rat in vivo fetal-to-maternal transfer clearances of various xenobiotics by umbilical perfusion.
    Nishimura T; Takanohashi T; Tomi M; Horikoshi M; Higuchi K; Sai Y; Nakashima E
    J Pharm Sci; 2013 Sep; 102(9):3356-63. PubMed ID: 23620249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.